CRISPR THERAPEUTICS AG

Ticker: CRSP CUSIP: H17182108 Class: NAMEN AKT

NORDEA INVESTMENT MANAGEMENT AB's Holding History (CIK: 0001218210)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 131,300 Value ($000) $8,394 Avg Close $57.41 Range $46.60 - $71.13
Q2 2025
Shares 127,500 Value ($000) $6,249 Avg Close $38.70 Range $30.04 - $51.52
Q1 2025
Shares 126,600 Value ($000) $4,315 Avg Close $42.39 Range $32.96 - $55.88
Q4 2024
Shares 125,400 Value ($000) $4,913 Avg Close $47.22 Range $38.20 - $59.07
Q3 2024
Shares 120,100 Value ($000) $5,657 Avg Close $50.74 Range $43.42 - $63.68
Q2 2024
Shares 126,900 Value ($000) $6,898 Avg Close $57.84 Range $51.02 - $68.39
Q1 2024
Shares 148,700 Value ($000) $10,305 Avg Close $71.59 Range $58.29 - $91.10
Q4 2023
Shares 105,600 Value ($000) $6,677 Avg Close $55.02 Range $37.55 - $76.97
Q3 2023
Shares 108,100 Value ($000) $5,043 Avg Close $51.65 Range $44.53 - $59.67
Q2 2023
Shares 95,300 Value ($000) $5,488 Avg Close $56.74 Range $43.10 - $72.00
Q1 2023
Shares 101,200 Value ($000) $4,548 Avg Close $48.57 Range $39.88 - $58.50
Q4 2022
Shares 102,000 Value ($000) $4,049 Avg Close $53.05 Range $38.94 - $66.31
Q3 2022
Shares 87,900 Value ($000) $5,786 Avg Close $72.47 Range $60.41 - $86.95
Q2 2022
Shares 88,700 Value ($000) $5,392 Avg Close $58.79 Range $42.51 - $75.42
Q1 2022
Shares 97,000 Value ($000) $6,266 Avg Close $62.79 Range $50.54 - $79.40
Q4 2021
Shares 94,100 Value ($000) $7,549 Avg Close $87.36 Range $67.15 - $112.39
Q3 2021
Shares 75,600 Value ($000) $8,497 Avg Close $125.59 Range $109.63 - $163.00